She adjusts my dose based on how I am tolerating it
The Phase 2 trial of retatrutide (Jastreboff et al., New England Journal of Medicine , 2023) reported that the most common adverse effects were gastrointestinal in nature (nausea, vomiting, diarrhoea), consistent with the GLP-1 receptor agonist class
I had tried diet pills in the past, but nothing really worked long term. However, within a month of starting Semaglutide, John noticed a significant reduction in his appetite
One telemedicine service that has been generating considerable buzz lately is Ellie MD
Can GLP-1 drugs benefit patients who are not obese
Injection therapy is quick and typically completed within minutes